Bronchodilator Response and Health Outcomes in COPD Patients
Author Information
Author(s): Hanania Nicola A, Sharafkhaneh Amir, Celli Bartolome, Decramer Marc, Lystig Ted, Kesten Steven, Tashkin Donald
Primary Institution: Baylor College of Medicine
Hypothesis
Does acute bronchodilator responsiveness predict long-term outcomes in COPD patients?
Conclusion
Acute bronchodilator responsiveness does not predict long-term health outcomes in COPD patients treated with tiotropium.
Supporting Evidence
- 52% of patients exceeded the threshold for bronchodilator responsiveness using criterion A.
- Statistically significant improvements in lung function were observed with tiotropium regardless of baseline bronchodilator responsiveness.
- Only a small minority of patients remained nonresponsive across multiple visits.
Takeaway
The study found that many COPD patients show varying responses to bronchodilators over time, and this doesn't help doctors decide on treatment with tiotropium.
Methodology
Patients underwent spirometry before and after bronchodilator administration during the UPLIFT trial, with outcomes assessed based on bronchodilator responsiveness.
Potential Biases
Potential bias due to reliance on patient self-reporting for smoking adherence.
Limitations
The study could only measure bronchodilator responses in the placebo group due to the long half-life of tiotropium.
Participant Demographics
Mean age was 64 years, 75% male, and 30% current smokers.
Statistical Information
P-Value
p<0.001
Confidence Interval
Not specified
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website